* NextGen Healthcare Inc NXGN.OQ NXGN.O is expected
to show a
rise in quarterly revenue when it reports results on July 26.
* The Atlanta Georgia-based company is expected to report
a
4.7% increase in revenue to $152.905 million from $146.08
million a year ago, according to the mean estimate from 5
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for NextGen Healthcare
Inc is
for earnings of 16 cents per share. For the same quarter last
year, the company reported earnings of 25 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 3
"hold" and 1 "sell" or "strong sell."
* The mean earnings estimate of analysts had fallen by
about 1.6%
in the last three months.
* Wall Street's median 12-month price target for NextGen
Healthcare Inc is $22, above its last closing price of $18.28.
* Previous quarterly performance (using preferred earnings
measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Mar. 31 2022 0.19 0.19 0.19 Met -2.2
Dec. 31 2022 0.20 0.21 0.24 Beat 15.2
Sep. 30 2021 0.24 0.23 0.29 Beat 26.1
Jun. 30 2021 0.21 0.21 0.25 Beat 20.3
Mar. 0.19 0.19 0.21 Beat 8.8
31 2021
Dec. 31 2020 0.24 0.25 0.26 Beat 5.4
Sep. 30 2020 0.20 0.20 0.30 Beat 48.5
Jun. 30 2020 0.08 0.08 0.21 Beat 152
This summary was machine generated July 23 at 01:36 GMT. All
figures in US dollars unless otherwise stated